CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Scope & Guideline

Connecting Researchers to the Future of Pharmaceuticals

Introduction

Explore the comprehensive scope of CURRENT PHARMACEUTICAL BIOTECHNOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore CURRENT PHARMACEUTICAL BIOTECHNOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1389-2010
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2000 to 2024
AbbreviationCURR PHARM BIOTECHNO / Curr. Pharm. Biotechnol.
Frequency15 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

CURRENT PHARMACEUTICAL BIOTECHNOLOGY focuses on the intersection of pharmaceuticals and biotechnology, emphasizing innovative therapeutic strategies, drug delivery systems, and the role of biopharmaceuticals in treating various diseases. The journal aims to disseminate cutting-edge research and reviews that contribute to advancements in drug development and biotechnology applications.
  1. Pharmaceutical Biotechnology:
    The journal covers the development and application of biopharmaceuticals, including novel drug formulations, targeted therapies, and personalized medicine approaches.
  2. Nanotechnology in Drug Delivery:
    A significant focus is on nanocarriers and nanotechnology-based systems that enhance drug delivery efficacy, targeting, and patient compliance.
  3. Natural Products and Herbal Medicine:
    Research on the pharmacological properties of medicinal plants and natural compounds is a core area, highlighting their potential in drug discovery and development.
  4. Molecular Mechanisms in Disease:
    The journal explores the molecular and cellular mechanisms underlying various diseases, including cancer, neurodegenerative disorders, and metabolic diseases, to identify therapeutic targets.
  5. Clinical and Translational Research:
    Emphasizing the translation of laboratory findings into clinical applications, the journal includes studies that bridge the gap between basic research and clinical practice.
  6. Regulatory and Safety Aspects of Pharmaceuticals:
    Discussion on regulatory challenges, safety assessments, and ethical considerations in the development and application of biopharmaceuticals is also integral to the journal's scope.
The landscape of CURRENT PHARMACEUTICAL BIOTECHNOLOGY is evolving, with several emerging themes gaining traction in recent publications. This section outlines these trends, which reflect the journal's adaptive focus on contemporary challenges and innovations in the field.
  1. Nanomedicine and Targeted Therapies:
    Research on nanomedicine, particularly in targeted cancer therapies and drug delivery systems, is on the rise, demonstrating the potential of nanotechnology in improving therapeutic outcomes.
  2. Immunotherapy and Biologics:
    There is an increasing emphasis on the development and application of immunotherapies and biologics, reflecting a broader trend in oncology and autoimmune disease management.
  3. Gut Microbiome and Health:
    Studies exploring the relationship between the gut microbiome and various health conditions, including metabolic and mental health disorders, are becoming more prominent, indicating a growing interest in microbiome-based therapies.
  4. Artificial Intelligence in Drug Discovery:
    The integration of artificial intelligence and machine learning in drug discovery processes is emerging as a significant trend, showcasing the potential for computational approaches to enhance drug development.
  5. Sustainable and Green Chemistry:
    Research focusing on environmentally friendly and sustainable practices in pharmaceutical development, including the use of green synthesis methods for nanoparticles and drug compounds, is gaining attention.

Declining or Waning

While CURRENT PHARMACEUTICAL BIOTECHNOLOGY continues to grow in various domains, certain themes are becoming less prominent. This section highlights areas of research that have seen a decline in focus or frequency of publication, indicating shifts in research priorities.
  1. Conventional Drug Delivery Systems:
    As the field shifts towards more innovative and targeted delivery systems, traditional drug delivery methods are receiving less attention, leading to a decline in related publications.
  2. Basic Pharmacology Studies:
    There has been a noticeable decrease in basic pharmacology research as the journal pivots towards more application-oriented studies, particularly in biopharmaceuticals and nanotechnology.
  3. Single-Agent Cancer Therapies:
    Research focusing solely on single-agent therapies is waning, with a growing emphasis on combination therapies and novel approaches that integrate multiple modalities.
  4. In Vitro Studies Without Clinical Relevance:
    Studies that lack direct clinical implications or translational potential are being published less frequently, as the journal prioritizes research that informs clinical practice.

Similar Journals

Journal of Pharmacy & Pharmacognosy Research

Advancing Knowledge in Pharmacy and Pharmacognosy
Publisher: JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRESISSN: 0719-4250Frequency: 6 issues/year

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

CURRENT PHARMACEUTICAL DESIGN

Pioneering Insights in Pharmacology and Drug Development
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1381-6128Frequency: 46 issues/year

CURRENT PHARMACEUTICAL DESIGN is a leading journal in the fields of Drug Discovery and Pharmacology, published by Bentham Science Publishers Ltd in the dynamic United Arab Emirates. With an impressive historical span from 1995 to 2024, this journal serves as a vital platform for disseminating innovative research findings, breakthrough methodologies, and critical reviews that shape the future of pharmaceutical sciences. Ranked Q2 in both Drug Discovery and Pharmacology categories according to the 2023 metrics, it places itself within the top-tier percentile, catering to a diverse audience of researchers, industry professionals, and students. The journal’s commitment to high-quality research exploration is evidenced by its Scopus ranking, where it is positioned favorably within its category ranks. Although currently not Open Access, CURRENT PHARMACEUTICAL DESIGN remains an essential resource for those looking to stay at the forefront of pharmacological advancements and drug development strategies.

BMC BIOTECHNOLOGY

Transforming Ideas into Biotechnological Breakthroughs
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Biotechnology, a leading journal in the field of biotechnology, is published by BMC and has been a pivotal platform for open-access research since 2000. With a focus on the diverse areas of biotechnology, including biochemistry, genetics, and molecular biology, this journal holds a prestigious Q2 ranking in its category for 2023 and demonstrates a commendable percentile rank in the top 66th for its Scopus listings. Operating out of the United Kingdom and covering research from 2001 to 2024, BMC Biotechnology is committed to disseminating high-quality, rigorously peer-reviewed articles that foster advancements and innovations in the biotechnology landscape. Researchers, professionals, and students alike will benefit from the journal's rich content and dedicated commitment to enhancing scientific discourse within the realm of biotechnology.

Current Pharmaceutical Analysis

Catalyzing Discoveries in Biochemistry and Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4129Frequency: 6 issues/year

Current Pharmaceutical Analysis, published by Bentham Science Publishers Ltd, is a vital resource for professionals and researchers in the fields of Pharmaceutical Science, Biochemistry, and Molecular Medicine. Established in 2006, this peer-reviewed journal aims to provide a platform for the latest advancements and analytical methodologies in pharmaceutical research and drug development. Over the years, it has garnered attention for its rigorous scrutiny and contributions to the landscape of pharmacology, evidenced by its quartile placements in various categories, most notably Q3 in Pharmaceutical Science. Despite its current rankings placing it in the lower quartile in several disciplines, the journal remains an essential venue for both emerging and established researchers seeking to disseminate their findings. With the widespread accessibility of its articles, researchers, professionals, and students can engage with cutting-edge studies to foster innovation in pharmaceutical analysis. For access to the latest research contributions, readers can explore the digital archive and stay updated on pivotal discussions shaping the future of the pharmaceutical sciences.

Expert Opinion on Drug Delivery

Advancing Drug Delivery Innovation for Better Patient Outcomes
Publisher: TAYLOR & FRANCIS LTDISSN: 1742-5247Frequency: 12 issues/year

Expert Opinion on Drug Delivery is a leading journal in the field of pharmaceutical science, published by Taylor & Francis Ltd. With an impressive impact factor and a prestigious Q1 ranking in 2023, it stands out as a vital resource for researchers, professionals, and students dedicated to advancing drug delivery technologies. Established in 2004, the journal has consistently provided a platform for critical insights and expert analyses, bridging the gap between innovation and application in drug delivery systems. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to the fields of pharmacology, toxicology, and pharmaceutics. With its robust ranking of 13th out of 183 in Scopus, the journal continues to foster discourse and collaboration among experts, thereby enhancing the advancement of therapeutic options and improving patient outcomes.

Pharmaceutical Sciences

Advancing pharmaceutical knowledge for a healthier future.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

Minerva Biotechnology and Biomolecular Research

Fostering Knowledge in the Dynamic World of Biomolecular Research
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-542XFrequency: 4 issues/year

Minerva Biotechnology and Biomolecular Research is an emerging journal published by EDIZIONI MINERVA MEDICA, dedicated to the fields of biotechnology, biomolecular research, and applied microbiology. With an ISSN of 2724-542X and an E-ISSN of 2724-5934, this journal aims to foster deeper understanding and innovative advancements in these rapidly evolving disciplines. The journal has been categorized in the Q4 quartile across four categories in the 2023 rankings, highlighting its nascent yet growing influence within the scientific community. Operating on an open-access model, it enhances accessibility and encourages the dissemination of knowledge to researchers, professionals, and students alike. Set in the heart of Italy, specifically at CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY, Minerva Biotechnology and Biomolecular Research will continue to enrich the scientific literature from its inception in 2021 through 2024 and beyond, contributing to the global dialogue on biotechnological innovations and molecular research.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Fostering breakthroughs in drug development and application.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

Frontiers in Pharmacology

Advancing pharmacological frontiers for a healthier tomorrow.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

Iranian Journal of Pharmaceutical Research

Fostering a vibrant community of pharmaceutical researchers.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.